Greater skeletal gains in ovary intact rats at maturity are achieved by supplementing a standardized extract of Butea monosperma stem bark that confers better bone conserving effect following ovariectomy and concurrent treatment withdrawal

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Srivastava, Kamini ^a   Khan, Kainat ^a   Tyagi, Abdul M ^a   Khan, Mohd P ^a   Yadav, Dinesh K ^a   Trivedi, Ritu ^a   Maurya, Rakesh ^a   Singh, Divya ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ACETONE SOLUBLE FRACTION; ANTIOXIDANT; ESTRADIOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BARK; BIOMECHANICS; BONE GROWTH; BONE STRENGTH; BONE TURNOVER; BUTEA MONOSPERMA; CONTROLLED STUDY; FEMALE; FRACTIONATION; MATURATION; MATURITY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; PLANT STEM; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; TRABECULAR BONE; TREATMENT WITHDRAWAL; WEANING;

EID: 84877983303     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/519387     Document Type: Article

References (44)

1. Kanis J. A., Alexeeva L., Bonjour J. P., Burkhardt P., Christiansen C., Cooper C., Delmas P., Johnell O., Johnston C., Kanis J. A., Khaltaev N., Lips P., Mazzuoli G., Melton L. J., Meunier P., Seeman E., Stepan J., Tosteson A., Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis International 1994 4 6 368 381 2-s2.0-0028556527 10.1007/BF01622200
2. Orwoll E. S., Belknap J. K., Klein R. F., Gender specificity in the genetic determinants of peak bone mass. Journal of Bone and Mineral Research 2001 16 11 1962 1971 2-s2.0-0034778448 (Pubitemid 32995387)
3. Matkovic V., Fontana D., Tominac C., Goel P., Chesnut C. H. III, Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. American Journal of Clinical Nutrition 1990 52 5 878 888 2-s2.0-0025048929
4. Bonjour J., Chevalley T., Rizzoli R., Ferrari S., Gene-environment interactions in the skeletal response to nutrition and exercise during growth. Medicine and Sport Science 2007 51 64 80 2-s2.0-34547693534 10.1159/000103005
5. Kwok A. W., Leung J. C., Chan A. Y., Au B. S., Lau E. M., Yurianto H., Yuktanandana P., Yoshimura N., Muraki S., Oka H., Akune T., Leung P. C., Prevalence of vertebral fracture in Asian men and women: comparison between Hong Kong, Thailand, Indonesia and Japan. Public Health 2012 126 523 531 10.1016/j.puhe.2012.03.002
6. Seeman E., Growth in bone mass and size are racial and gender differences in bone mineral density more apparent than real? Journal of Clinical Endocrinology and Metabolism 1998 83 5 1414 1419 2-s2.0-0032068774 10.1210/jc.83.5.1414 (Pubitemid 28500995)
7. Lees C. J., Kaplan J. R., Chen H., Jerome C. P., Register T. C., Franke A. A., Bone mass and soy isoflavones in socially housed, premenopausal macaques. American Journal of Clinical Nutrition 2007 86 1 245 250 2-s2.0-34447258146 (Pubitemid 47041617)
8. Zittermann A., Geppert J., Baier S., Zehn N., Gouni-Berthold I., Berthold H. K., Reinsberg J., Stehle P., Short-term effects of high soy supplementation on sex hormones, bone markers, and lipid parameters in young female adults. European Journal of Nutrition 2004 43 2 100 108 2-s2.0-2442703993 10.1007/s00394-004-0447-5 (Pubitemid 38661223)
9. Anderson J. J. B., Chen X., Boass A., Symons M., Kohlmeier M., Renner J. B., Garner S. C., Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. Journal of the American College of Nutrition 2002 21 5 388 393 2-s2.0-0036789026
10. Greendale G. A., FitzGerald G., Huang M. H., Sternfeld B., Gold E., Seeman T., Sherman S., Sowers M., Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. American Journal of Epidemiology 2002 155 8 746 754 2-s2.0-0037090216 10.1093/aje/155.8.746 (Pubitemid 34297655)
11. Nakai M., Cook L., Pyter L. M., Black M., Sibona J., Turner R. T., Jeffery E. H., Bahr J. M., Dietary soy protein and isoflavones have no significant effect on bone and a potentially negative effect on the uterus of sexually mature intact Sprague-Dawley female rats. Menopause 2005 12 3 291 298 2-s2.0-16244392961 10.1097/01.GME.0000146109.50235.DO (Pubitemid 40667529)
12. Walle T., Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Molecular Pharmaceutics 2007 4 6 826 832 2-s2.0-37549024168 10.1021/mp700071d
13. Choi S. Y., Ha T. Y., Ahn J. Y., Kim S. R., Kang K. S., Hwang I. K., Kim S., Estrogenic activities of isoflavones and flavones and their structure-activity relationships. Planta Medica 2008 74 1 25 32 2-s2.0-39149092009 10.1055/s-2007-993760 (Pubitemid 351251379)
14. Pandey R., Gautam A. K., Bhargavan B., Trivedi R., Swarnkar G., Nagar G. K., Yadav D. K., Kumar M., Rawat P., Manickavasagam L., Kumar A., Maurya R., Goel A., Jain G. K., Chattopadhyay N., Singh D., Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction. Menopause 2010 17 3 602 610 2-s2.0-77952275063 10.1097/gme.0b013e3181d0f7f0
15. Gautam A. K., Bhargavan B., Tyagi A. M., Srivastava K., Yadav D. K., Kumar M., Singh A., Mishra J. S., Singh A. B., Sanyal S., Maurya R., Manickavasagam L., Singh S. P., Wahajuddin W., Jain G. K., Chattopadhyay N., Singh D., Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. Journal of Nutritional Biochemistry 2011 22 4 318 327 2-s2.0-78651239360 10.1016/j.jnutbio.2010.02.010
16. Bhargavan B., Gautam A. K., Singh D., Kumar A., Chaurasia S., Tyagi A. M., Yadav D. K., Mishra J. S., Singh A. B., Sanyal S., Goel A., Maurya R., Chattopadhyay N., Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. Journal of Cellular Biochemistry 2009 108 2 388 399 2-s2.0-70349246398 10.1002/jcb.22264
17. Tyagi A. M., Gautam A. K., Kumar A., Srivastava K., Bhargavan B., Trivedi R., Saravanan S., Yadav D. K., Singh N., Pollet C., Brazier M., Mentaverri R., Maurya R., Chattopadhyay N., Goel A., Singh D., Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Molecular and Cellular Endocrinology 2010 325 1-2 101 109 10.1016/j.mce.2010.05.016
18. Cheng P. T., Aye L. M., Vieth R., Muller K., Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen. Bone 1995 17 4 329S 334S 2-s2.0-0028786771
19. Sharan K., Siddiqui J. A., Swarnkar G., Tyagi A. M., Kumar A., Rawat P., Kumar M., Nagar G. K., Arya K. R., Manickavasagam L., Jain G. K., Maurya R., Chattopadhyay N., Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect. Menopause 2010 17 2 393 402 2-s2.0-77949407107 10.1097/gme.0b013e3181bfae38
20. Khan K., Sharan K., Swarnkar G., Chakravarti B., Mittal M., Barbhuyan T. K., China S. P., Khan M. P., Nagar G. K., Yadav D., Dixit P., Maurya R., Chattopadhyay N., Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation. Osteoporosis International 2012 24 4 1455 1470 10.1007/s00198-012-2121-8
21. Sharan K., Mishra J. S., Swarnkar G., Siddiqui J. A., Khan K., Kumari R., Rawat P., Maurya R., Sanyal S., Chattopadhyay N., A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action. Journal of Bone and Mineral Research 2011 26 9 2096 2111 10.1002/jbmr.434
22. Bouxsein M. L., Boyd S. K., Christiansen B. A., Guldberg R. E., Jepsen K. J., Müller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. Journal of Bone and Mineral Research 2010 25 7 1468 1486 2-s2.0-77954756294 10.1002/jbmr.141
23. Parfitt A. M., Bone histomorphometry: proposed system for standardization of nomenclature, symbols, and units. Calcified Tissue International 1988 42 5 284 286 2-s2.0-0024009641 10.1007/BF02556360
24. Foldes J., Shih M. S., Parfitt A. M., Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces. Journal of Bone and Mineral Research 1990 5 10 1063 1067 2-s2.0-0025013946 (Pubitemid 20371552)
25. Sharan K., Swarnkar G., Siddiqui J. A., Kumar A., Rawat P., Kumar M., Nagar G. K., Manickavasagam L., Singh S. P., Mishra G., Wahajuddin, Jain G. K., Maurya R., Chattopadhyay N., A novel flavonoid, 6-C- β -d-glucopyranosyl- (2S,3S)-(+)-3′ 4′5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats. Menopause 2010 17 3 577 586 2-s2.0-77952291901 10.1097/gme.0b013e3181d2ce7f
26. Tabensky A., Duan Y., Edmonds J., Seeman E., The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures. Journal of Bone and Mineral Research 2001 16 6 1101 1107 2-s2.0-0035014333 (Pubitemid 32467154)
27. Szulc P., Seeman E., Duboeuf F., Sornay-Rendu E., Delmas P. D., Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. Journal of Bone and Mineral Research 2006 21 12 1856 1863 2-s2.0-33845202518 10.1359/jbmr.060904 (Pubitemid 44851561)
28. Delmas P. D., How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone 2000 27 1 1 3 2-s2.0-0034080243 10.1016/S8756-3282(00)00301-X (Pubitemid 30365070)
29. Wattel A., Kamel S., Mentaverri R., Lorget F., Prouillet C., Petit J. P., Fardelonne P., Brazier M., Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochemical Pharmacology 2003 65 1 35 42 2-s2.0-0037212767 10.1016/S0006- 2952(02)01445-4 (Pubitemid 35447836)
30. Choi E. M., Koo S. J., Effects of soybean ethanol extract on the cell survival and oxidative stress in osteoblastic cells. Phytotherapy Research 2003 17 6 627 632 2-s2.0-0037787792 10.1002/ptr.1213 (Pubitemid 36781738)
31. Wauquier F., Leotoing L., Coxam V., Guicheux J., Wittrant Y., Oxidative stress in bone remodelling and disease. Trends in Molecular Medicine 2009 15 10 468 477 10.1016/j.molmed.2009.08.004
32. Pfeiffer E., Treiling C. R., Hoehle S. I., Metzler M., Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis 2005 26 12 2172 2178 2-s2.0-27944483765 10.1093/carcin/bgi197 (Pubitemid 41672205)
33. Elsby R., Maggs J. L., Ashby J., Paton D., Sumpter J. P., Park B. K., Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. Journal of Pharmacology and Experimental Therapeutics 2001 296 2 329 337 2-s2.0-0035146540 (Pubitemid 32112457)
34. Roach H. I., Mehta G., Oreffo R. O. C., Clarke N. M. P., Cooper C., Temporal analysis of rat growth plates: cessation of growth with age despite presence of a physis. Journal of Histochemistry and Cytochemistry 2003 51 3 373 383 2-s2.0-0037369940 (Pubitemid 36245993)
35. Singh D., Sanyal S., Chattopadhyay N., The role of estrogen in bone growth and formation: changes at puberty. Cell Health and Cytoskeleton 2011 3 1 2 12 2-s2.0-79952684450 10.2147/CHC.S8916
36. Kazama J. J., Koda R., Yamamoto S., Narita I., Gejyo F., Tokumoto A., Cancellous bone volume is an indicator for trabecular bone connectivity in dialysis patients. Clinical Journal of the American Society of Nephrology 2010 5 2 292 298 2-s2.0-77749334656 10.2215/CJN.04150609
37. Lis Mosekilde E. N. E., Tornvig L., Thomsen J. S., Trabecular bone structure and strength-remodelling and repair. Journal of Musculoskeletal and Neuronal Interactions 2000 1 25 30
38. Kinney J. H., Ladd A. J. C., The relationship between three-dimensional connectivity and the elastic properties of trabecular bone. Journal of Bone and Mineral Research 1998 13 5 839 845 2-s2.0-0031978185 10.1359/jbmr.1998.13.5.839 (Pubitemid 28224200)
39. Lane N. E., Kumer J. L., Majumdar S., Khan M., Lotz J., Stevens R. E., Klein R., Phelps K. V., The effects of synthetic conjugated estrogens, a (Cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporosis International 2002 13 10 816 823 2-s2.0-0036820570 10.1007/s001980200113 (Pubitemid 36336727)
40. Brouwers J. E. M., Van Rietbergen B., Huiskes R., Ito K., Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT. Osteoporosis International 2009 20 11 1823 1835 2-s2.0-76449089952 10.1007/s00198-009-0882-5
41. Cano A., Dapía S., Noguera I., Pineda B., Hermenegildo C., Del Val R., Caeiro J. R., García-Pérez M. A., Comparative effects of 17 β -estradiol, raloxifene and genistein on bone 3D microarchitecture and volumetric bone mineral density in the ovariectomized mice. Osteoporosis International 2008 19 6 793 800 2-s2.0-43249086703 10.1007/s00198-007-0498-6 (Pubitemid 351652523)
42. Österman T., Laurén L., Kuurtamo P., Hannuniemi R., Isaksson P., Kippo K., Peng Z., Väänänen H. K., Sellman R., The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats. Journal of Pharmacology and Experimental Therapeutics 1998 284 1 312 316 2-s2.0-0031884979 (Pubitemid 28109561)
43. Seibel M. J., Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. The Clinical Biochemist Reviews 2006 27 123 138
44. Balena R., Toolan B. C., Shea M., Markatos A., Myers E. R., Lee S. C., Opas E. E., Seedor J. G., Klein H., Frankenfield D., Quartuccio H., Fioravanti C., Clair J., Brown E., Hayes W. C., Rodan G. A., The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. Journal of Clinical Investigation 1993 92 6 2577 2586 2-s2.0-0027139913 (Pubitemid 24006520)